Unlisted
| Company Name | 주식회사 바이오인프라 |
| English Name | BioInfra Co.,Ltd. |
| Business Reg. No. | 1358191937 |
| CEO | 이상득 |
| Address | 경기도 용인시 기흥구 흥덕중앙로 120 4층, 5층 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | Contact |
| Phone | 031-627-2800 |
| Website | bioinfrakorea.co.kr |
| Regular Employees | 141persons |
| Corp. Reg. No. | 1358110139949 |
Venture Certified
| 기술평가보증기업(기금) | 2008-03-12 ~ 2009-03-11 | 20080101080 | 2008-03-12 |
| 기술평가보증기업(기금) | 2009-03-12 ~ 2010-03-11 | 20090103143 | 2008-03-12 |
| 기술평가보증기업(기금) | 2010-08-05 ~ 2012-08-04 | 20100106204 | 2008-03-12 |
| 기술평가보증기업(기금) | 2012-08-05 ~ 2014-08-04 | 20120108912 | 2008-03-12 |
| 기술평가보증기업(기금) | 2014-08-05 ~ 2016-08-04 | 20140110062 | 2008-03-12 |
| 연구개발유형 | 2016-08-05 ~ 2018-08-04 | 20160110540 | 2008-03-12 |
| 기술평가보증기업(기금) | 2018-08-05 ~ 2020-08-04 | 20180110575 | 2008-03-12 |
| 기술평가보증기업(기금) | 2020-08-05 ~ 2022-08-04 | 20200111856 | 2008-03-12 |
| 혁신성장유형 | 2022-08-05 ~ 2025-08-04 | 20220831030009 | 2008-03-12 |
| 혁신성장유형 | 2025-08-05 ~ 2028-08-04 | 20250820030080 | 2008-03-12 |
Revenue CAGR -18.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 238B | 301B | 354B |
| Operating Profit | -51B | 13B | 64B |
| Net Profit | -59B | 13B | 70B |
| Total Assets | 411B | 470B | 326B |
| Total Liabilities | 136B | 130B | 147B |
| Total Equity | 276B | 340B | 179B |
Operating Loss: Op. profit -51B
▼ 27.3%
▼ 233.5%
▼ 292.7%
▼ 18.3%
▼ 199.7%
| Name | Position | Role |
|---|---|---|
| 이상득 | 대표이사 | 대표 |
| Regular Employees | 141persons |
| CEO | 이상득 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 삼중 블록 코폴리머 구조의 초음파 감응형 약물전달체 및 이에 대한 제조 방법 | (주) 바이오인프라생명과학 | 1020230102484 | 2023-08-04 | 공개 |
| 더블 에멀젼 구조의 초음파 감응형 약물전달체 | (주) 바이오인프라생명과학 | 1020220158574 | 2022-11-23 | 거절 |
| 더블 에멀젼 구조의 초음파 감응형 약물전달체를 생성하는 방법 | (주) 바이오인프라생명과학 | 1020220158575 | 2022-11-23 | 공개 |
| 소수성 약물을 전달하기 위한 초음파 감응형 약물전달체를 생성하는 방법 및 이를 이용한 초음파 감응형 약물전달체 | (주) 바이오인프라생명과학 | 1020220086875 | 2022-07-14 | 등록 |
| 약물을 전달하기 위한 초음파 감응형 약물전달체를 생성하는 방법 및 이를 이용한 초음파 감응형 약물전달체 | (주) 바이오인프라생명과학 | 1020220075143 | 2022-06-20 | 거절 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
2 Additional Data Sources
{
"address": "경기도 용인시",
"ceo_name": "이상득",
"certificate": [
{
"cert_number": "20080101080",
"changes": "",
"disclosure_date": "2008-03-12",
"first_cert_date": "2008-03-12",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2008-03-12 ~ 2009-03-11"
},
{
"cert_number": "20090103143",
"changes": "",
"disclosure_date": "2009-04-10",
"first_cert_date": "2008-03-12",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-03-12 ~ 2010-03-11"
},
{
"cert_number": "20100106204",
"changes": "",
"disclosure_date": "2010-08-05",
"first_cert_date": "2008-03-12",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-08-05 ~ 2012-08-04"
},
{
"cert_number": "20120108912",
"changes": "",
"disclosure_date": "2012-11-14",
"first_cert_date": "2008-03-12",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-08-05 ~ 2014-08-04"
},
{
"cert_number": "20140110062",
"changes": "",
"disclosure_date": "2014-09-11",
"first_cert_date": "2008-03-12",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-08-05 ~ 2016-08-04"
},
{
"cert_number": "20160110540",
"changes": "",
"disclosure_date": "2016-09-09",
"first_cert_date": "2008-03-12",
"no": "6",
"type": "연구개발유형",
"valid_period": "2016-08-05 ~ 2018-08-04"
},
{
"cert_number": "20180110575",
"changes": "",
"disclosure_date": "2018-09-04",
"first_cert_date": "2008-03-12",
"no": "7",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-08-05 ~ 2020-08-04"
},
{
"cert_number": "20200111856",
"changes": "",
"disclosure_date": "2020-09-09",
"first_cert_date": "2008-03-12",
"no": "8",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-08-05 ~ 2022-08-04"
},
{
"cert_number": "20220831030009",
"changes": "",
"disclosure_date": "2022-08-31",
"first_cert_date": "2008-03-12",
"no": "9",
"type": "혁신성장유형",
"valid_period": "2022-08-05 ~ 2025-08-04"
},
{
"cert_number": "20250820030080",
"changes": "",
"disclosure_date": "2025-08-20",
"first_cert_date": "2008-03-12",
"no": "10",
"type": "혁신성장유형",
"valid_period": "2025-08-05 ~ 2028-08-04"
}
],
"company_name": "주식회사 바이오인프라",
"financials": {
"2022": {
"capital_stock": 2063684000,
"cost_of_sales": 21455082000,
"current_assets": 12866881000,
"current_liabilities": 6374600000,
"gross_profit": 13972286000,
"net_income": 6986571000,
"net_income_bs": 6237199000,
"non_current_assets": 19722400000,
"non_current_liabilities": 8305180000,
"non_operating_expenses": 438659000,
"non_operating_income": 1065034000,
"operating_profit": 6360196000,
"revenue": 35427368000,
"sga_expenses": 7612090000,
"total_assets": 32589281000,
"total_equity": 17909502000,
"total_liabilities": 14679779000
},
"2023": {
"capital_stock": 2398434000,
"cost_of_sales": 20575463000,
"current_assets": 21408010000,
"current_liabilities": 8485458000,
"gross_profit": 9553272000,
"net_income": 1278521000,
"net_income_bs": 2001611000,
"non_current_assets": 25595812000,
"non_current_liabilities": 4544828000,
"non_operating_expenses": 604353000,
"non_operating_income": 577662000,
"operating_profit": 1305212000,
"revenue": 30128735000,
"sga_expenses": 8248060000,
"total_assets": 47003822000,
"total_equity": 33973535000,
"total_liabilities": 13030287000
},
"2024": {
"capital_stock": 2432184000,
"cost_of_sales": 18137082000,
"current_assets": 14764292000,
"current_liabilities": 9218559000,
"gross_profit": 5696127000,
"net_income": -5875649000,
"net_income_bs": -3976027000,
"non_current_assets": 26356749000,
"non_current_liabilities": 4334195000,
"non_operating_expenses": 1189109000,
"non_operating_income": 430243000,
"operating_profit": -5116783000,
"revenue": 23833209000,
"sga_expenses": 10812910000,
"total_assets": 41121041000,
"total_equity": 27568288000,
"total_liabilities": 13552754000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"phone": "031-627-****",
"source": "pg_migration"
}{
"address": "경기 용인시 기흥구 흥덕중앙로 120 5층(영덕동, U-타워 지2층, 4층, 5층)",
"employee_count": 141,
"establishment_date": "20070601",
"source": "pg_migration",
"workplace_name": "(주)바이오인프라"
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| SME Status Info | 2026-03-05 | Collected |
| comwel_insurance | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |